Pegylated -IFN-α 2B treatment of chronic hepatitis C can lead to MN, while no recurrence of kidney disease was observed after stopping the treatment of IFN (Gianassi et al., 2019). This evidence concerns the gene IFNA1 and chronic hepatitis C virus infection.